UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057635
Receipt number R000065852
Scientific Title Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis: non-randomized controlled trial
Date of disclosure of the study information 2025/04/17
Last modified on 2025/12/15 15:10:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis

Acronym

Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis

Scientific Title

Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis: non-randomized controlled trial

Scientific Title:Acronym

ESWT-PRP trial for KOA-BML

Region

Japan


Condition

Condition

knee osteoarthritis

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effects of combined extracorporeal shock wave and PRP therapy for bone marrow lesions associated with knee osteoarthritis on clinical symptoms, knee joint function and motor function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Knee flexion range of motion, knee extension range of motion, knee extension muscle strength, hip abduction muscle strength, timed up & go test. time: before intervention, 1 month, 3 months, 5 months

Key secondary outcomes

Patient-reported outcome measures: Visual analogue scale, Knee injury and osteoarthritis outcome score, Hospital Anxiety and Ultrasonographic assessment: Distance in suprapatellar sac,Medial meniscal extrusion, Muscle brightness of medial vastus medialis.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Extracorporeal shock wave (2000 shots, 3 times a week), injection of multi-platelet plasma (once), physical therapy (once a week for 5 months)

Interventions/Control_2

Extracorporeal shock wave (2000 shots, 3 times a week), physical therapy (once a week for 5 months)

Interventions/Control_3

physical therapy (once a week for 5 months)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with osteoarthritis of the knee, with a Visual Analogue Scale evaluation of 30 mm or more at the medial knee joint and bone marrow lesions at the medial tibiofemoral joint on MRI.

Key exclusion criteria

Grade IV in the Kellgren-Lawrence classification, prior ESWT or PRP therapy, history of knee trauma or neurological disease, bilateral symptomatic knee osteoarthritis, bone marrow lesions with osteonecrosis on MRI findings, systemic diseases such as rheumatoid arthritis, autoimmune diseases, tumors, and contraindications to ESWT systemic diseases such as rheumatoid arthritis, autoimmune diseases, and tumors, as well as those with contraindications to extracorporeal shock wave therapy.

Target sample size

39


Research contact person

Name of lead principal investigator

1st name Shintarou
Middle name
Last name Kudo

Organization

Morinomiya University of Medical Sciences

Division name

Inclusive Medical Sciences Research Institute

Zip code

559-8611

Address

1-26-16 Nankoukita, Suminoe-ward, Osaka-city, Osaka

TEL

0666166911

Email

kudo@morinomiya-u.ac.jp


Public contact

Name of contact person

1st name shun
Middle name
Last name okada

Organization

Morinomiya University of Medical Sciences

Division name

research support center

Zip code

559-8611

Address

1-26-16 Nankoukita, Suminoe-ward, Osaka-city, Osaka

TEL

0666166911

Homepage URL


Email

kenkyu@morinomiya-u.ac.jp


Sponsor or person

Institute

Morinomiya University of Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Morinomiya University of Medical Sciences

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Morinomiya University of Medical Sciences

Address

1-26-16 Nankoukita, Suminoe-ward, Osaka-city, Osaka

Tel

0666166911

Email

kenkyu@morinomiya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 04 Month 17 Day

Date of IRB

2024 Year 12 Month 26 Day

Anticipated trial start date

2025 Year 04 Month 17 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 17 Day

Last modified on

2025 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065852